Frontiers Development of an AmpliSeqTM Panel for Next-Generation Sequencing of a Set of Genetic Predictors of Persisting Pain

Cytokines Stimulate GTP Cyclohydrolase I Gene Expression in Cultured Human Umbilical Vein Endothelial Cells

The performance of genome sequencing as a first-tier test for neurodevelopmental disorders

One in seven pathogenic variants can be challenging to detect by NGS: An analysis of 450,000 patients with implications for clinical sensitivity and genetic test implementation

Genomic profiling informs diagnoses and treatment in vascular anomalies

Genetic risk signatures of opioid-induced respiratory depression following pediatric tonsillectomy

Frontiers Amplicon-Based NGS Panels for Actionable Cancer Target Identification in Follicular Cell-Derived Thyroid Neoplasia

µ-opioid receptor gene variant OPRM1 118 A>G: a summary of its molecular and clinical consequences for pain

A multiplexed, next generation sequencing platform for high-throughput detection of SARS-CoV-2

When should we order a next generation sequencing test in a patient with cancer? - eClinicalMedicine

Frontiers Development of an AmpliSeqTM Panel for Next-Generation Sequencing of a Set of Genetic Predictors of Persisting Pain

Functional polymorphisms and methotrexate treatment outcome in recent-onset rheumatoid arthritis

Genetic risk signatures of opioid-induced respiratory depression following pediatric tonsillectomy

A deep learning model for predicting next-generation sequencing depth from DNA sequence

Frontiers Vitamin D, FOXO3a, and Sirtuin1 in Hashimoto's Thyroiditis and Differentiated Thyroid Cancer

A Novel Targeted Amplicon Next-Generation Sequencing Gene Panel for the Diagnosis of Common Variable Immunodeficiency Has a High Diagnostic Yield - The Journal of Molecular Diagnostics